Concern right now over terfenadine

    There's lots of concern right now over terfenadine.

    There have been hundreds of reports of arrhythmias and sudden death associated with terfenadine.

    The FDA is trying to take Seldane, Seldane-D, and the generics off the market completely.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote